Consider current large-scale practices for oligonucleotide synthesis as a basis for improving commercial-scale platform strategies.
Isaiah Cedillo
Advertisement
Isaiah Cedillo is director of manufacturing and operations at Ionis Pharmaceuticals.
Articles by Isaiah Cedillo
Advertisement
Latest Updated Articles
Designing Commercial-Scale Oligonucleotide SynthesisPublished: February 2nd 2020 | Updated:
Advertisement
Advertisement
